Embed this press release by copying the code below:
NASDAQ: ACRX Investor Notice: Deadline on August 9, 2021 in Lawsuit Against AcelRx Pharmaceuticals, Inc.
NASDAQ: ACRX Investor Notice: Deadline on August 9, 2021 in Lawsuit Against AcelRx Pharmaceuticals, Inc.